Temporal expression of MOF acetyltransferase primes transcription factor networks for erythroid fate
Author(s) -
Cecília Pessoa Rodrigues,
Josip S. Herman,
Benjamin Herquel,
Claudia Isabelle Keller Valsecchi,
Thomas Stehlé,
Dominic Grün,
Asifa Akhtar
Publication year - 2020
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.aaz4815
Subject(s) - biology , microbiology and biotechnology , chromatin , transcription factor , chromatin immunoprecipitation , cell fate determination , runx1 , h3k4me3 , gata1 , histone , haematopoiesis , stem cell , genetics , gene expression , gene , promoter
Self-renewal and differentiation of hematopoietic stem cells (HSCs) are orchestrated by the combinatorial action of transcription factors and epigenetic regulators. Here, we have explored the mechanism by which histone H4 lysine 16 acetyltransferase MOF regulates erythropoiesis. Single-cell RNA sequencing and chromatin immunoprecipitation sequencing uncovered that MOF influences erythroid trajectory by dynamic recruitment to chromatin and its haploinsufficiency causes accumulation of a transient HSC population. A regulatory network consisting of MOF, RUNX1, and GFI1B is critical for erythroid fate commitment. GFI1B acts as a activator which is necessary and sufficient for cell type-specific induction of expression. Plasticity of -depleted HSCs can be rescued by expression of a downstream effector, , or by rebalancing acetylation via a histone deacetylase inhibitor. Accurate timing and dosage of expression act as a rheostat for the feedforward transcription factor network that safeguards progression along the erythroid fate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom